AI company Anthropic announced the establishment of a life sciences research team and lab, and revealed early results from Claude's participation in biological research. Researchers stated that Claude identified a previously undescribed enzyme system after analyzing over 200,000 reverse transcriptase sequences, naming it "Array-associated Reverse Transcriptase" (ART). Following this news, A-share AI pharmaceutical concept stocks saw an unusual surge in early trading, with Berry Genomics hitting its daily limit.